What is Cabaletta Bio Inc (CABA) stock price today?

Cabaletta Bio Inc (CABA) currently trades at $2.78 per share. The stock has a market capitalization of $328.40M and a P/E ratio of —x.

Is CABA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Cabaletta Bio Inc has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -2.01.

Is Cabaletta Bio Inc financially healthy?

Cabaletta Bio Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -2.01 places it in the distress.

CABA

Cabaletta Bio Inc

NASDAQ: CABA · HEALTHCARE · BIOTECHNOLOGY

$2.78

-2.80% today

Updated 2026-04-29

Market cap

$328.40M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.10

Dividend yield

—

52W range

$1 – $4

Volume

2.2M

Market cap

$328.40M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.10

Dividend yield

—

52W range

$1 – $4

Volume

2.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-2.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$13.12

+371.94%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy7 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.18x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -2.01 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-35.55M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-51.81M	$-67.67M	$-115.86M	$-167.86M	$-41.92M
EPS	—	—	—	—	$-2.10
Free cash flow	$-48.83M	$-54.24M	$-90.43M	$-132.31M	$-35.55M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-02	NICHTBERGER, STEVEN	Buy	674,000	—
2026-03-02	MARDA, ANUP	Buy	225,000	—
2026-03-02	GERARD, MICHAEL	Buy	175,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CABA	$328.40M	27	4.3	3.0	5.0	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Cabaletta Bio Inc trades at $2.78. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -2.01, it sits in the distress.

Frequently asked questions

What is Cabaletta Bio Inc's stock price?

Cabaletta Bio Inc (CABA) trades at $2.78.

Is Cabaletta Bio Inc overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Cabaletta Bio Inc (CABA)?

The analyst target price is $13.12, representing +371.9% upside from the current price of $2.78.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-2.01 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-127.00%

Beta3.29

50D MA$3.09

200D MA$2.41

Shares out0.11B

Float0.09B

Short ratio—

Avg volume2.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CABA vs LLY →CABA vs JNJ →CABA vs ABBV →Stock screener →